| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.069 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |